Cargando…

67 CF patients with a declining FEV(1): At risk for acquisition of Burkholderia cepacia complex infection?

INTRODUCTION: Burkholderia cepacia complex (Bcc) infection is considered to be associated with worsening of CF lung disease. Patient to patient spread has been reported, however mechanisms of acquisition of Bcc are not well understood. Method: Data from the Belgian CF Registry (year 2000–2010) were...

Descripción completa

Detalles Bibliográficos
Autores principales: Willekens, J., Wanyama, S., Thomas, M., De Wachter, E., De Schutter, I., Malfroot, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Cystic Fibrosis Society. Published by Elsevier B.V. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129951/
http://dx.doi.org/10.1016/S1569-1993(15)30244-7
_version_ 1783516901201149952
author Willekens, J.
Wanyama, S.
Thomas, M.
De Wachter, E.
De Schutter, I.
Malfroot, A.
author_facet Willekens, J.
Wanyama, S.
Thomas, M.
De Wachter, E.
De Schutter, I.
Malfroot, A.
author_sort Willekens, J.
collection PubMed
description INTRODUCTION: Burkholderia cepacia complex (Bcc) infection is considered to be associated with worsening of CF lung disease. Patient to patient spread has been reported, however mechanisms of acquisition of Bcc are not well understood. Method: Data from the Belgian CF Registry (year 2000–2010) were collected. Inclusions: Bcc infected patients with entries on lung function in at least 1 y before and 3 y after Bcc acquisition. For each case, we included 2 controls, matched for age at the index year (year of first Bcc infection), pancreatic status, sex. Cumulative data up to 2 years before index year were compared to values obtained after infection using Rank sum test. Rate of decline in lung function was adjusted for baseline lung function, age, sex. RESULTS: Bcc prevalence in CF is low in Belgium (<3%). 183 patients were included: 61 cases, 122 controls. 59% were F508del homozygous. Mean age in cases was 20.9 y (SD 10.5) vs 20.3 y (SD 10.3) in controls. Among the Bcc, 54% were unspecified, 31% were B. multivorans. Mean FEV(1) at index year was 65.2% (SD 24.9) in cases vs 73.1 (SD 26.9) in controls (p = 0.07). FEV(1) decline before index year was significantly higher in cases (–1.7%, SD 0.5) compared to controls (–1.0%, SD 0.3) (p = 0.002). FEV(1) slopes were comparable in the period after index year (–1.1%, SD 0.5, in cases vs –0.99%, SD 0.4, p = 0.24). CONCLUSION: Our results suggest that a declining FEV(1) precedes acquisition of Bcc and may be a risk factor. After acquisition, lung function decline was comparable in Bcc infected and uninfected patients. These results should be interpreted with caution, since registry data are collected retrospectively and bear a risk of incompleteness or inaccuracy.
format Online
Article
Text
id pubmed-7129951
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher European Cystic Fibrosis Society. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-71299512020-04-08 67 CF patients with a declining FEV(1): At risk for acquisition of Burkholderia cepacia complex infection? Willekens, J. Wanyama, S. Thomas, M. De Wachter, E. De Schutter, I. Malfroot, A. J Cyst Fibros Article INTRODUCTION: Burkholderia cepacia complex (Bcc) infection is considered to be associated with worsening of CF lung disease. Patient to patient spread has been reported, however mechanisms of acquisition of Bcc are not well understood. Method: Data from the Belgian CF Registry (year 2000–2010) were collected. Inclusions: Bcc infected patients with entries on lung function in at least 1 y before and 3 y after Bcc acquisition. For each case, we included 2 controls, matched for age at the index year (year of first Bcc infection), pancreatic status, sex. Cumulative data up to 2 years before index year were compared to values obtained after infection using Rank sum test. Rate of decline in lung function was adjusted for baseline lung function, age, sex. RESULTS: Bcc prevalence in CF is low in Belgium (<3%). 183 patients were included: 61 cases, 122 controls. 59% were F508del homozygous. Mean age in cases was 20.9 y (SD 10.5) vs 20.3 y (SD 10.3) in controls. Among the Bcc, 54% were unspecified, 31% were B. multivorans. Mean FEV(1) at index year was 65.2% (SD 24.9) in cases vs 73.1 (SD 26.9) in controls (p = 0.07). FEV(1) decline before index year was significantly higher in cases (–1.7%, SD 0.5) compared to controls (–1.0%, SD 0.3) (p = 0.002). FEV(1) slopes were comparable in the period after index year (–1.1%, SD 0.5, in cases vs –0.99%, SD 0.4, p = 0.24). CONCLUSION: Our results suggest that a declining FEV(1) precedes acquisition of Bcc and may be a risk factor. After acquisition, lung function decline was comparable in Bcc infected and uninfected patients. These results should be interpreted with caution, since registry data are collected retrospectively and bear a risk of incompleteness or inaccuracy. European Cystic Fibrosis Society. Published by Elsevier B.V. 2015-06 2015-06-05 /pmc/articles/PMC7129951/ http://dx.doi.org/10.1016/S1569-1993(15)30244-7 Text en Copyright © 2015 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Willekens, J.
Wanyama, S.
Thomas, M.
De Wachter, E.
De Schutter, I.
Malfroot, A.
67 CF patients with a declining FEV(1): At risk for acquisition of Burkholderia cepacia complex infection?
title 67 CF patients with a declining FEV(1): At risk for acquisition of Burkholderia cepacia complex infection?
title_full 67 CF patients with a declining FEV(1): At risk for acquisition of Burkholderia cepacia complex infection?
title_fullStr 67 CF patients with a declining FEV(1): At risk for acquisition of Burkholderia cepacia complex infection?
title_full_unstemmed 67 CF patients with a declining FEV(1): At risk for acquisition of Burkholderia cepacia complex infection?
title_short 67 CF patients with a declining FEV(1): At risk for acquisition of Burkholderia cepacia complex infection?
title_sort 67 cf patients with a declining fev(1): at risk for acquisition of burkholderia cepacia complex infection?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129951/
http://dx.doi.org/10.1016/S1569-1993(15)30244-7
work_keys_str_mv AT willekensj 67cfpatientswithadecliningfev1atriskforacquisitionofburkholderiacepaciacomplexinfection
AT wanyamas 67cfpatientswithadecliningfev1atriskforacquisitionofburkholderiacepaciacomplexinfection
AT thomasm 67cfpatientswithadecliningfev1atriskforacquisitionofburkholderiacepaciacomplexinfection
AT dewachtere 67cfpatientswithadecliningfev1atriskforacquisitionofburkholderiacepaciacomplexinfection
AT deschutteri 67cfpatientswithadecliningfev1atriskforacquisitionofburkholderiacepaciacomplexinfection
AT malfroota 67cfpatientswithadecliningfev1atriskforacquisitionofburkholderiacepaciacomplexinfection